[Skip to Content]
[Skip to Content Landing]
November 1987

Serum Lipoprotein in Active Rheumatoid Arthritis and Other Chronic Inflammatory ArthritidesII. Effects of Anti-inflammatory and Disease-Modifying Drug Treatment

Author Affiliations

From the Section of Rheumatology, Department of Internal Medicine, University Hospital (Drs Svenson and Hällgren), and the Department of Geriatrics, University of Uppsala (Drs Lithell and Vessby), Uppsala, Sweden.

Arch Intern Med. 1987;147(11):1917-1920. doi:10.1001/archinte.1987.00370110045006

• Serum lipids and lipoprotein patterns were prospectively analyzed in 33 previously untreated patients with active chronic inflammatory arthritides during different anti-inflammatory and disease-modifying drug regimens. Before treatment the lipoprotein pattern was characterized by low cholesterol concentrations in all lipoprotein fractions and low triglyceride concentrations in the very-low-density lipoprotein fraction as well as in the high-density lipoprotein fraction. During treatment with prednisolone combined with azathioprine or cyclophosphamide (n =10), a reduction of the disease activity was achieved and the lipoprotein pattern was normalized; similar results were noted in a small group of patients (n = 4) treated with prednisolone alone while nonsteroidal anti-inflammatory drug therapy (n = 9) neither significantly affected the lipoprotein pattern nor the inflammatory activity measured by the acute-phase reactants. The long-term treatment with penicillamine (n = 4) and chloroquine (n = 6) induced both a clinical remission of the disease and a reduction of the inflammatory activity. The lipoprotein concentrations started to reverse to the normal values during penicillamine treatment. In contrast, in the chloroquine-treated group the alterations in lipoprotein lipid concentrations were further pronounced, ie, the cholesterol and triglyceride concentrations in serum and the very-low-density lipoprotein fraction decreased.

(Arch Intern Med 1987;147:1917-1920)